Document:

Exhibit
10.3

 

OptimizeRx
Corporation

2021
Equity Incentive Plan

 

Notice of Stock Option Grant

 

You (the
“Optionee”) have been granted the following option (the “Option”) to purchase Common Stock of
OptimizeRx Corporation (the “Company”), par value $0.001 per share (“Share”), pursuant to the
OptimizeRx Corporation 2021 Equity Incentive Plan (the “Plan”):

 

	Name of Optionee:	 	[Name]
	 	 	 
	Total Number of Shares Subject to Option:	 	 [# of Shares]
	 	 	 
	Type of Option:	 	[ISO or NQO]
	 	 	 
	Exercise Price Per Share:	 	$[Price]
	 	 	 
	
    Date of Grant:

     

    Vesting Schedule:
	 	
    [DATE]

     

    See below

	 	 	 
	Expiration Date:	 	[DATE]

 

The vesting and exercisability of the Option is
contingent upon (i) the Company’s achievement of the performance target(s) set forth on Exhibit A hereto (“Performance
Goal(s)”) during the Performance Period set forth on Exhibit A hereto, and (ii) the Grantee’s continued employment or
service (as applicable) with the Company through the end of the Performance Period1.
The Option will vest and become exercisable only after certification by the Committee of the achievement of the Performance Goals previously
established and approved by the Committee for the Performance Period.

 

By your signature and the signature of the Company’s
representative below, you and the Company agree and acknowledge that this Option is granted under and governed by the terms and conditions
of the Plan and the attached Stock Option Agreement, which are incorporated herein by reference, and that you have been provided with
a copy of the Plan and Stock Option Agreement.

 

	Optionee:	 	OptimizeRx Corporation:
	 	 	 	 	 
	By:	                	 	By:	              
	 	 	 	 	 
	Name:		 	Name:	         
	 	 	 	 	 
			 	Title:	

 

 

	1	Note: This form assumes that the service-based vesting
condition matches Performance Period. If the service-based vesting condition does not match Performance Period, this paragraph will be
revised accordingly.

 

     

     

    

 

OptimizeRx
Corporation

2021
Equity Incentive Plan

 

Stock Option Agreement

 

Section 1. Grant of Option.

 

(a) Option. On
the terms and conditions set forth in the Notice of Stock Option Grant (the “Grant Notice”) and this Stock Option Agreement
(the “Agreement”), the Company grants to the Optionee on the Date of Grant the option (the “Option”)
to purchase at the Exercise Price the number of Shares set forth in the Grant Notice.   If designated in the Notice of Stock
Option Grant as an Incentive Stock Option, this Option is intended to qualify as an Incentive Stock Option as defined in Section 422
of the Code. Nevertheless, to the extent that it exceeds the $100,000 rule of Code Section 422(d), this Option shall be treated as
a Nonqualified Stock Option. Further, if for any reason this Option (or portion thereof) shall not qualify as an Incentive Stock Option,
then, to the extent of such nonqualification, such Option (or portion thereof) shall be regarded as a Nonqualified Stock Option granted
under the Plan. In no event shall the Committee, the Company or any Parent or Subsidiary or any of their respective employees or directors
have any liability to the Optionee (or any other person) due to the failure of the Option to qualify for any reason as an Incentive Stock
Option.

 

(b) Plan
and Defined Terms. The Option is granted pursuant to the Plan. All terms, provisions, and conditions applicable to the Option
set forth in the Plan and not set forth herein are hereby incorporated by reference herein. To the extent any provision hereof is inconsistent
with a provision of the Plan, the provisions of the Plan will govern. All capitalized terms that are used in the Grant Notice or this
Agreement and not otherwise defined therein or herein shall have the meanings ascribed to them in the Plan.

 

Section 2. Right to Exercise. The Option
hereby granted shall be exercised by written notice to the Committee, specifying the number of Shares the Optionee desires to purchase
together with provision for payment of the Exercise Price. Payment of the Exercise Price may be made by check payable to the order of
the Company, for an amount in United States dollars equal to the aggregate Exercise Price of such Shares or by any other payment method
described in Section 5 of the Plan. The Company may require the Optionee to furnish or execute such other documents as the Company shall
reasonably deem necessary (i) to evidence such exercise and (ii) to comply with or satisfy the requirements of the Securities
Act of 1933, as amended, the Exchange Act, applicable state or non-U.S. securities laws or any other law.

 

Section 3. Term and Expiration.

 

(a) Basic
Term. Subject to earlier termination pursuant to the terms here, the Option shall expire on the expiration date set forth in
the Grant Notice.

 

(b) Termination
of Employment. Subject to Section 10(d) of the Plan, in the event of the Optionee’s Termination of Employment, the Option
shall expire on the earliest of the following occasions:

 

(i) The expiration
date set forth in the Grant Notice;

 

(ii) The date three months
following the Optionee’s Termination of Employment for any reason other than Cause, Disability, death or, if this is a Nonqualified
Stock Option, Retirement;

 

(iii) The date one year
following the Optionee’s Termination of Employment due to Disability, death or, if this is a Nonqualified Stock Option, Retirement;
or

 

(iv) The date of
the Optionee’s Termination of Employment for Cause.

 

The Optionee may exercise
all or part of this Option at any time before its expiration under the preceding sentence, but, subject to the following sentence, only
to the extent that the Option had become vested before the Optionee’s Termination of Employment. Subject to Section 10(d) of the
Plan, when the Optionee’s employment or service terminates, this Option shall expire immediately with respect to the number of Shares
for which the Option is not yet vested. If the Optionee dies after Termination of Employment, but before the expiration of the Option,
all or part of this Option may be exercised (prior to expiration) by the personal representative of the Optionee or by any person who
has acquired this Option directly from the Optionee by will, bequest or inheritance until the one year anniversary of the Optionee’s
death, but only to the extent that the Option was vested and exercisable upon the Optionee’s Termination of Employment.

 

    2

     

    

 

Section 4. Transferability of Option.

 

The Option shall not be transferable
by the Optionee other than by will or the laws of descent and distribution, and the Option shall be exercisable during the Optionee’s
lifetime only by the Optionee or on his or her behalf by the Optionee’s guardian or legal representative.

 

Section 5. Change in Control.

 

Except as otherwise set forth
in an Individual Agreement between the Grantee and the Company or a Subsidiary or Affiliate, Section 10 of the Plan shall govern the treatment
of the Option in connection with a Change in Control.

 

Section 6. Miscellaneous Provisions.

 

(a) Acknowledgements. The
Optionee hereby acknowledges that he or she has read and understands the terms of the Plan and this Agreement and agrees to be bound by
their respective terms and conditions. The Optionee acknowledges that there may be tax consequences upon the exercise or transfer of the
Option and that the Optionee should consult an independent tax advisor prior to any exercise of the Option.

 

(b) Tax
Withholding.  No later than the date as of which an amount first becomes includible in the gross income of the Optionee for federal,
state, local or foreign income or employment or other tax purposes with respect to the Option, the Optionee shall pay to the Company,
or make arrangements satisfactory to the Company regarding the payment of, any federal, state, local or foreign taxes of any kind required
by law to be withheld with respect to such amount. Withholding obligations may be settled with Shares having a Fair Market Value on the
date of withholding equal to the minimum amount required to be withheld for tax purposes, all in accordance with such procedures as the
Committee establishes. The Committee may condition the delivery of Shares upon the Optionee’s satisfaction of such withholding obligations.

 

(c) Notice
Concerning Disqualifying Dispositions. If the Option is an Incentive Stock Option, the Optionee shall notify the Committee of
any disposition of Shares issued pursuant to the exercise of the Option if the disposition constitutes a “disqualifying disposition”
within the meaning of Sections 421 and 422 of the Code (or any successor provision of the Code then in effect relating to disqualifying
dispositions). Such notice shall be provided by the Optionee to the Committee in writing within 10 days of any such disqualifying
disposition. A disposition constitutes a “disqualifying disposition” if the disposition of the Shares acquired upon exercise
of the Incentive Stock Option occurs before the second anniversary of the Date of Grant or before the first anniversary of the date the
Shares were acquired by the Optionee through exercise of the Incentive Stock Option.

 

(d) Rights
as a Stockholder. Neither the Optionee nor the Optionee’s transferee or representative shall have any rights as a stockholder
with respect to any Shares subject to this Option until the Option has been exercised and Share certificates have been issued to the Optionee,
transferee or representative, as the case may be.

 

(e) Ratification
of Actions. By accepting this Agreement, the Optionee and each person claiming under or through the Optionee shall be conclusively
deemed to have indicated the Optionee’s acceptance and ratification of, and consent to, any action taken under the Plan or this
Agreement and Grant Notice by the Company, the Board, or the Committee.

 

(f) Notice. Any
notice required by the terms of this Agreement shall be given in writing or in such other form as the Committee may accept. Notice in
writing shall be deemed effective upon personal delivery or upon deposit with the United States Postal Service, by registered or certified
mail, with postage and fees prepaid. Notice shall be addressed to the Company at its principal executive office and to the Optionee at
the address that he or she most recently provided in writing to the Company.

 

    3

     

    

 

(g) Choice
of Law. This Agreement and the Grant Notice shall be governed by, and construed in accordance with, the laws of the State of
Nevada, without regard to any conflicts of law or choice of law rule or principle that might otherwise cause the Plan, this Agreement
or the Grant Notice to be governed by or construed in accordance with the substantive law of another jurisdiction.

 

(h) Modification
or Amendment. This Agreement may only be modified or amended by written agreement executed by the parties hereto; provided, however,
that the adjustments permitted pursuant to Section 3(e) and Section 10 of the Plan may be made without such written agreement.

 

(i) Severability. In
the event any provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect
the remaining provisions of this Agreement, and this Agreement shall be construed and enforced as if such illegal or invalid provision
had not been included.

 

(j) References
to Plan. All references to the Plan shall be deemed references to the Plan as it may be amended from time to time.

 

(k) Section 409A
Compliance. To the extent applicable, it is intended that the Plan and this Agreement comply with the requirements of Code Section 409A
and any related regulations or other guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal
Revenue Service and the Plan and the Award Agreement shall be interpreted accordingly.

 

    4

     

    

 

OptimizeRx
Corporation

 

STOCK OPTION AGREEMENT

 

EXHIBIT A

 

[insert vesting conditions based on achievement of Performance Goals]

 

For purposes of this Award:

 

		(a)	“Performance Goal” means [one or more of the following performance criteria, either individually, alternatively
or in any combination, applied either to the Company as a whole or on any one or more Subsidiaries or Affiliates or business units of
the Company or a Subsidiary or Affiliate and may be measured relative to a peer group, an index or a business plan and may be considered
as absolute measures or changes in measures, relative to a pre-established target or to a previous year’s results, in each case
as specified by the Committee in the agreement evidencing the option award: (a) income; (b) expense; (c) operating cash flow; (d) capital
spending; (e) total shareholder return, (f) gross margin, (g) growth in revenues, sales, market share, gross income, net income, pre-tax
income, stock price, and/or earnings per share, return on assets, net assets, and/or capital, working capital, free cash flow and/or after
tax cash flow, earnings before interest and taxes (EBIT), earnings before interest, taxes, depreciation, and amortization (EBITDA); (h)
EBITDA plus stock compensation; (i) return on shareholders’ equity, return on invested capital (j) economic or shareholder value
added, acquisition of assets, (k) acquisition of companies; (l) creation of new joint ventures; (m) growth in new products; (n) lower
product acquisition costs and/or improvements in costs and/or expenses; (o) stock price hurdles; and (p) other objective financial or
service-based standards relevant to the Company’s business as may be established by the Committee, subject to adjustment by the
Committee to eliminate the effects of the following items: (i) extraordinary, unusual, and/or nonrecurring items of gain or loss; (ii) gains
or losses on the disposition of a business; (iii) dividends declared on the Company’s stock; (iv) changes in tax or accounting
principles, regulations or laws; or (v) expenses incurred in connection with a merger, acquisition or similar transaction.]

 

		(b)	“Performance Period” means [_________________].

 

 

5EXHIBIT 10.4

 

OptimizeRx
Corporation

2021
Equity Incentive Plan

 

Notice of Restricted Stock Unit Grant

 

You (the “Grantee”)
have been granted the following award of Restricted Stock Units (“Restricted Stock Units” or “RSUs”)
with respect to shares of OptimizeRx Corporation (the “Company”)
common stock, par value $0.001 per share (the “Shares”), pursuant to the OptimizeRx Corporation 2021 Equity Incentive
Plan (the “Plan”).

  

	 	Name of Grantee:	 	[NAME]
	 	 	 	 
	 	Number of Restricted Stock Units Granted:	 	[NUMBER]
	 	 	 	 
	 	Date of Grant:	 	[DATE]
	 	 	 	 
	 	Vesting and Period of Restriction:	 	[VESTING SCHEDULE]

  

By
your signature and the signature of the Company’s representative below, you and the Company agree and acknowledge that this grant
of Restricted Stock Units is granted under and governed by the terms and conditions of the Plan and the attached Restricted Stock Unit
Award Agreement, which are incorporated herein by reference, and that you have been provided with a copy of the Plan and Restricted Stock
Unit Agreement.

 

	Optionee:	 	OptimizeRx
    Corporation:
	 	 	 	 	 
	By:	         	 	By:	           
	 	 	 	 	 
	Name:		 	Name:	
	 	 	 	 	 
			 	Title:	 

 

    

     

    

 

OptimizeRx
Corporation

2021
Equity Incentive Plan

 

Restricted Stock Unit Award Agreement

 

Section 1. Grant of Restricted Stock Unit

 

(a) Restricted
Stock Unit. On the terms and conditions set forth in the Notice of Restricted Stock Unit Grant (the “Grant Notice”)
and this Restricted Stock Unit Award Agreement (this “Agreement”), the Company grants to the Grantee on the Date of
Grant the right to receive the number of Restricted Stock Units set forth in the Grant Notice. Each RSU represents the right to receive
one Share to be issued and delivered at the end of the Period of Restriction, subject to the risk of forfeiture described herein.

 

(b) Plan and
Defined Terms. The RSUs are granted pursuant to the Plan. All terms, provisions, and conditions applicable to the RSUs set forth
in the Plan and not set forth herein are hereby incorporated by reference herein. To the extent any provision hereof is inconsistent with
a provision of the Plan, the provisions of the Plan will govern. All capitalized terms that are used in the Grant Notice or this Agreement
and not otherwise defined therein or herein shall have the meanings ascribed to them in the Plan.

 

Section 2. Forfeiture and Transfer Restrictions

 

(a) Forfeiture
Restrictions. Subject to Section 10(d) of the Plan, in the event of the Grantee’s Termination of Employment for any reason,
the Grantee shall, for no consideration, forfeit to the Company the RSUs to the extent such RSUs are subject to a Period of Restriction
at the time of such termination.

 

(b) Transfer
Restrictions. During the Period of Restriction, the RSUs may not be sold, assigned, pledged, exchanged, hypothecated or otherwise
transferred, encumbered or disposed of to the extent such RSUs are subject to a Period of Restriction.

 

(c) Lapse of
Restrictions; Delivery of Shares. The Period of Restriction shall lapse as to the RSUs in accordance with the Grant Notice. Vested
RSUs will be settled by delivery of Shares. As soon as practicable after the end of the Period of Restriction (but in no event later than
75 days thereafter), the number of Shares of the vested RSUs (minus any withholding for taxes) shall be delivered to the Grantee. The
number of Shares that shall be delivered (less withholding for taxes) shall equal the number of vested RSUs. If the Grantee dies before
any payment due hereunder is made, such delivery shall be made to the Grantee’s beneficiary. If Shares are issued, they shall be
registered in the Grantee’s name in certificate or book entry form as soon as practicable following delivery of the Shares. Once
delivery of a Share has been made with respect to a RSU, the RSU shall be canceled.

 

Section 3. Change in Control.

 

Except as otherwise set forth
in an Individual Agreement between the Grantee and the Company or a Subsidiary or Affiliate, Section 10 of the Plan shall govern the treatment
of the RSUs in connection with a Change in Control.

 

Section 4. Miscellaneous Provisions

 

(a) Tax Withholding. No
later than the date as of which an amount first becomes includible in the gross income of the Grantee for federal, state, local or foreign
income or employment or other tax purposes with respect to the RSU, the Grantee shall pay to the Company, or make arrangements satisfactory
to the Company regarding the payment of, any federal, state, local or foreign taxes of any kind required by law to be withheld with respect
to such amount. Withholding obligations may be settled with Shares having a Fair Market Value on the date of withholding equal to the
minimum amount required to be withheld for tax purposes, all in accordance with such procedures as the Committee establishes. The Committee
may condition the delivery of Shares in respect of vested RSUs upon the Grantee’s satisfaction of such withholding obligations.

 

    2

     

    

 

(b) Rights
as Stockholder. Neither Grantee nor any person claiming under or through Grantee shall have any of the rights or privileges of a stockholder
of the Company in respect of any Shares issuable hereunder unless and until certificates representing such Shares (which may be in uncertificated
form) have been issued and recorded on the books and records of the Company or its transfer agents or registrars, and delivered to Grantee
(including through electronic delivery to a brokerage account). After such issuance, recordation and delivery, Grantee shall have all
the rights of a stockholder of the Company, including with respect to the right to vote the Shares and the right to receive any cash or
share dividends or other distributions paid to or made with respect to the Shares. Cash dividends on Shares underlying RSUs shall accrue
in cash and be paid only to the extent the underlying RSU vests.

 

(c) Ratification
of Actions. By accepting this Agreement, the Grantee and each person claiming under or through the Grantee shall be conclusively
deemed to have indicated the Grantee’s acceptance and ratification of, and consent to, any action taken under the Plan or this Agreement
and Grant Notice by the Company, the Board, or the Committee.

 

(d) Choice
of Law. This Agreement and the Grant Notice shall be governed by, and construed in accordance with, the laws of the State of
Nevada, without regard to any conflicts of law or choice of law rule or principle that might otherwise cause the Plan, this Agreement
or the Grant Notice to be governed by or construed in accordance with the substantive law of another jurisdiction.

 

(e) Modification
or Amendment. This Agreement may only be modified or amended by written agreement executed by the parties hereto; provided, however,
that the adjustments permitted pursuant to Section 3(e) and Section 10 of the Plan may be made without such written agreement.

 

(f) Severability. In
the event any provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect
the remaining provisions of this Agreement, and this Agreement shall be construed and enforced as if such illegal or invalid provision
had not been included.

 

(g) References to
Plan. All references to the Plan shall be deemed references to the Plan as it may be amended from time to time.

 

(h) Section 409A
Compliance. To the extent applicable, it is intended that the Plan and this Agreement comply with the requirements of Code Section 409A
and any related regulations or other guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal
Revenue Service and the Plan and the Award Agreement shall be interpreted accordingly.

 

 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]